COMMUNIQUÉS West-GlobeNewswire

Chiesi and Durham Bulls Partnership Steps up to Bat for Local Charities
22/04/2019
As the season’s presenting strikeouts sponsor, Chiesi pledges to donate to three area nonprofits CARY, N.C., April 22, 2019 (GLOBE NEWSWIRE) -- Starting today, Chiesi (key-A-zee), a Cary-based specialty pharmaceutical [...]
CohBar Announces the Appointment of David Greenwood to its Board of Directors
22/04/2019
Board expansion adds significant biotechnology operational and financial expertise MENLO PARK, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing [...]
Progyny Launches Special “This is Infertility” Podcast Episodes in Honor of National Infertility Awareness Week
22/04/2019
New York City, April 22, 2019 (GLOBE NEWSWIRE) -- Progyny, the leading fertility benefits management company, announced today the launch of a special, “This is Infertility” podcast series. The four episodes are aimed to [...]
RxGen to Deliver Multiple Presentations at Association for Research in Vision and Ophthalmology Annual Meeting
22/04/2019
NEW HAVEN, Conn., April 22, 2019 (GLOBE NEWSWIRE) -- RxGen, a preclinical translational research company, today announced that the company will be presenting at the Association for Research in Vision and Ophthalmology [...]
Teligent Provides Update on Orphan Drug Complete Response Letter
22/04/2019
BUENA, N.J., April 22, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that on April 16, 2019, its development partner has filed the [...]
Syneos Health Wins Best CRO Award at the Vaccine Industry Excellence Awards
22/04/2019
Award Recognizes Company’s Vaccine Expertise, Spanning End-to-End Clinical and Commercial Solutions MORRISVILLE, N.C., April 22, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated [...]
Hemispherx Biopharma Names Ellen Lintal as New Chief Accounting Officer
22/04/2019
OCALA, Fla., April 22, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma, Inc., an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in immunology, today [...]
Shineco, Inc. Enters into Strategic Cooperation Frame Agreement with Shenzhen Datong Industrial Co., Ltd
22/04/2019
BEIJING, April 22, 2019 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and [...]
Menlo Therapeutics to Present at the Class of 2018 Biotech IPOs Investor Day
22/04/2019
REDWOOD CITY, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), [...]
CorMedix Announces Online Pre-Clinical Abstract at the Upcoming Annual Meeting of American Society of Clinical Oncology
22/04/2019
BERKELEY HEIGHTS, N.J., April 22, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment [...]
Aduro Biotech Appoints Dimitry S.A. Nuyten, M.D., Ph.D. as Chief Medical Officer
22/04/2019
BERKELEY, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical stage biopharmaceutical company developing therapies in the Stimulator of Interferon Genes (STING) and A Proliferation [...]
LogicBio Therapeutics Expands Leadership Team and Bolsters Capabilities to Support GeneRide™ Platform Development and Advancement of Lead Program into Clinic
22/04/2019
Company’s move into new facilities triples lab space CAMBRIDGE, Mass., April 22, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a genome editing company focused on developing medicines to durably [...]
Adynxx Announces Merger Agreement with Alliqua BioMedical and Provides Business and Clinical Update
22/04/2019
Adynxx announced plans to merge with Alliqua BioMedical and become a Nasdaq-listed public company in early 2019 Company announced receipt of substantial grant award from the National Institute on Drug Abuse to support [...]
Molecular Templates Announces FDA Acceptance of IND Application for MT-5111, An Engineered Toxin Body Targeting HER2
22/04/2019
Dosing in Phase I Study in Patients with HER2-Positive Cancers Expected to Start in 3Q19 AUSTIN, Texas, April 22, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM) a clinical stage biopharmaceutical [...]
Gritstone Oncology Announces Clinical Acceleration of “Off-The-Shelf” Personalized Neoantigen Immunotherapy Program (SLATE) Following FDA Feedback
22/04/2019
EMERYVILLE, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), an immuno-oncology company developing tumor-specific cancer immunotherapies to fight multiple cancer types, today announced [...]
Tabula Rasa HealthCare Continues Growth Trajectory by Expanding Integrated Services in PACE
22/04/2019
Subsidiary companies now support all aspects of PACE health plan management MOORESTOWN, N.J., April 22, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC), a leading provider of technology- [...]
Axogen, Inc. Announces Completion of Planned Interim Analysis and One-Time Enrollment Expansion for RECON® Study
22/04/2019
Company to Expand Enrollment by 50 Subjects to Support Planned Power of the Study ALACHUA, Fla., April 22, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative [...]
Axogen, Inc. to Report First Quarter 2019 Financial Results and Host Conference Call on May 8, 2019
22/04/2019
ALACHUA, Fla., April 22, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced [...]
ProQR to Present at Three Scientific Conferences in April
22/04/2019
LEIDEN, Netherlands and CAMBRIDGE, Mass., April 22, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]

Pages